NIA Invests $90m into PREVENTABLE Study Determining the Benefits of Statins (atorvastatin) in the Elderly with Duke and Wake Forest Leading the Effort

The National Institute on Aging (NIA) has funded a major study by a North Carolina initiative including Wake Forest School of Medicine and Duke University Medical Center to investigate overall benefits and risks of cholesterol-lowering drugs knowns as statins in adults age 85 or older without cardiovascular disease. This trial will help determine whether a statin can help prevent dementia and disability in this age group, as well as heart attacks and other cardiovascular-related deaths, while not increasing risks of adverse health outcomes. The sponsors and investigators will tap into the U.S Department of VA and the National Patient-Centered Clinical Research Network for participants and associated records.


